A Clinical Research Study for Adults with Fibromyalgia
Neurovations Research in Napa, California will soon be enrolling adults with fibromyalgia in a clinical research study. If you or a loved one has fibromyalgia and other treatments haven’t worked, you may qualify to participate in clinical research right here in Northern California.
- Study Medication Provided: Every participant receives the study medication for the first 12 weeks.
- Local Expert Care: Supervised by the Neurovations clinical team.
About the Study
Advancing Research for Fibromyalgia Relief
This clinical research study is evaluating a study medication for adults living with fibromyalgia.
How the Trial Works
- Guaranteed Study Medication: For the first 12 weeks, every participant receives the study medication.
- Study Length: About 8 months.
Is this Study for me?
To be considered for participation at our Napa research center, candidates must meet the following primary criteria.
Age:
18 years of age or older
Treatment History:
Have tried two or more therapies for fibromyalgia that did not work
Current Medications:
Willing to stop current medications and take only the study-provided medication
Location:
Able to travel to the Neurovations Research center in Napa, CA for scheduled study visits
See If you Qualify
Complete the secure form below or call us at 707-252-9606. Our team will contact you within 48 hours.
Study Participation and Your Safety
Participant safety is our number one priority during every stage of the study process. All research studies are carefully supervised, monitored, and documented. Every research study is reviewed and approved by a special group of people called an Institutional Review Board (IRB) or an Ethics Committee (EC), which is made up of scientists, nonscientist professionals, and members of the public. They make sure that participants’ rights are protected, and they seek to avoid exposure to unnecessary risks. IRBs and ECs will only approve studies that they think could help
answer important medical questions.
While the research study is ongoing, a team of study doctors and nurses at the study site will closely monitor your health. If you have questions or concerns at any point throughout the study, a study staff member is available.
Your participation is voluntary, and you are free to withdraw at any time for any reason. Although others can help make up your mind, the final decision is yours to make. Your privacy will be maintained throughout the study.
About Neurovations Research
Neurovations Research, founded in 2010, is at the forefront of innovation in the field of pain and neuromodulation. CEO and founder Dr. Eric Grigsby has led clinical trials with more than fifty companies, partnering with industry leaders and early-stage companies in medical device (Phase I-IV) and pharmaceutical trials (Phase II-IV), including first-in-man medical device trials, double-blinded and placebo-controlled trials.